Neogen Corp $ 72.29 0.89 (1.25%)
Volume:
214,615
Avg Vol (1m):
540,078
Market Cap $:
3.83 Bil
Enterprise Value $:
3.47 Bil
P/E (TTM):
62.96
P/B:
5.11
Financial Strength | 10/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | No Debt | ||
| Equity-to-Asset | 0.92 | ||
| Interest Coverage | No Debt | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 34.85 | ||
| Beneish M-Score | -2.68 | ||
| WACC vs ROIC | |||
Profitability Rank | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 16.47 | ||
| Net Margin % | 14.24 | ||
| ROE % | 8.57 | ||
| ROA % | 7.85 | ||
| ROC (Joel Greenblatt) % | 31.38 | ||
| 3-Year Revenue Growth Rate | 4.2 | ||
| 3-Year EBITDA Growth Rate | 1.5 | ||
| 3-Year EPS without NRI Growth Rate | 9.5 |
NEOG
Valuation Rank | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 62.96 | ||
| Forward PE Ratio | 58.2 | ||
| PE Ratio without NRI | 62.96 | ||
| Price-to-Owner-Earnings | 59.99 | ||
| PB Ratio | 5.11 | ||
| PS Ratio | 9.01 | ||
| Price-to-Free-Cash-Flow | 58.63 | ||
| Price-to-Operating-Cash-Flow | 43.94 | ||
| EV-to-EBIT | 49.4 | ||
| EV-to-EBITDA | 39.02 | ||
| EV-to-Revenue | 8.15 | ||
| PEG Ratio | 11.52 | ||
| Shiller PE Ratio | 84.59 | ||
| Current Ratio | 11.99 | ||
| Quick Ratio | 9.89 | ||
| Days Inventory | 146.19 | ||
| Days Sales Outstanding | 66.55 | ||
| Days Payable | 41.12 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 6.74 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 3.49 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 3.65 | ||
| Price-to-Median-PS-Value | 1.31 | ||
| Price-to-Peter-Lynch-Fair-Value | 12.46 | ||
| Price-to-Graham-Number | 4.34 | ||
| Earnings Yield (Greenblatt) % | 2.02 | ||
| Forward Rate of Return (Yacktman) % | 6.31 |